Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
SHENZHEN YHLO BIOTECH CO., LTD. Shenzhen YHLO Biotech Co., Ltd. Stock price
Equities
688575
CNE100005204
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 23.77 CNY | -0.96% | +3.75% | +20.97% | |
| Oct. 27 | Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
| Sep. 18 | Shenzhen YHLO Biotech Co., Ltd.(XSSC:688575) added to S&P Global BMI Index | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site
| Sales 2023 * | 2,025 M 284 M | Sales 2024 * | 2,227 M 312 M | Capitalization | 13.50 B 1,895 M |
|---|---|---|---|---|---|
| Net income 2023 * | 368 M 51.64 M | Net income 2024 * | 509 M 71.42 M | EV / Sales 2023 * | 6,67x |
| Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 6,06x |
| P/E ratio 2023 * | 36,6x | P/E ratio 2024 * | 26,4x | Employees | 1,837 |
| Yield 2023 * | - | Yield 2024 * | - | Free-Float | 32.40% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.96% | ||
| 1 week | +3.75% | ||
| Current month | +5.97% | ||
| 1 month | +14.94% | ||
| 3 months | +51.59% | ||
| 6 months | +30.96% | ||
| Current year | +20.97% |
1 week
22.67
24.78
1 month
20.7424.78
Current year
15.3124.78
1 year
15.3129.98
3 years
15.3152.71
5 years
15.3152.71
10 years
15.3152.71
| Managers | Title | Age | Since |
|---|---|---|---|
Yong Bo Song
CEO | Chief Executive Officer | 39 | 2009 |
Shi Hong Pang
DFI | Director of Finance/CFO | 45 | 2018 |
Yu Jin Xiao
CTO | Chief Tech/Sci/R&D Officer | 47 | 2012 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shun Wen Zhang
BRD | Director/Board Member | 57 | 2020 |
Yi Zhou
BRD | Director/Board Member | 43 | 2016 |
Kun Hui Hu
CHM | Chairman | 32 | 2012 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.82% | 67 M€ | -3.29% | ||
| 0.31% | 128 M€ | -10.48% | - | |
| 0.13% | 21 M€ | -3.56% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23-11-28 | 23.77 | -0.96% | 3 953 821 |
| 23-11-28 | 24.00 | +1.61% | 3,518,450 |
| 23-11-27 | 23.62 | +0.51% | 2,991,835 |
| 23-11-24 | 23.50 | +0.64% | 3,531,136 |
| 23-11-23 | 23.35 | +2.86% | 2,936,731 |
End-of-day quote Shanghai Stock Exchange, November 28, 2023
More quotes
Shenzhen YHLO Biotech Co Ltd is a China-based company principally engaged in the research and development, manufacture and sales of in-vitro diagnostic equipment and supporting reagents, as well as the agency sales of some non-self-produced medical device products. The Company's products are applied in autoimmunity, reproductive health, diabetes and infectious disease fields. The Company's main products include in-vitro diagnostic instruments and supporting reagents based on chemiluminescence, immunoblotting, enzyme-linked immunoassay, immunofluorescence chromatography and other methodologies. The Company distributes its products in domestic market and to overseas markets.
Calendar
2024-04-28
- Q1 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
23.77CNY
Average target price
25.00CNY
Spread / Average Target
+5.17%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. (M$) | |
|---|---|---|
| +20.97% | 1 908 M $ | |
| +3.32% | 8 668 M $ | |
| -17.33% | 6 161 M $ | |
| +4.39% | 5 864 M $ | |
| +30.57% | 5 192 M $ | |
| -35.94% | 4 908 M $ | |
| +6.72% | 4 708 M $ | |
| +18.63% | 3 386 M $ | |
| -7.10% | 3 355 M $ | |
| -18.70% | 2 407 M $ |